|Articles|June 5, 2013
The Data Can Speak for Itself
Applied Clinical Trials Editorial talks with CluePoints' Founder Marc Buyse about the history of CluePoints as well as the role of biostatistics in clinical trials
Advertisement
In this interview Applied Clinical Trials Editorial Director Lisa Henderson talks with CluePoints' Founder Marc Buyse. They discuss the history of CluePoints as well as the role of biostatistics: "The Data Can Speak for Itself
SPOTLIGHT EVENT
Cambridge, MassachusettsDownload Brochure
RELATED
-
- Risk-Based Approach to Monitoring
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?More in Risk-Based Monitoring
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5